For instance, RyR1s contribute to acquired chemo-resistance by executing non-enzymatic interactions with chemotherapy-induced GSTO1 (glutathione S-transferase omega 1) to fine-tune cytosolic Ca2+ levels needed for the enrichment of the tumor-initiating breast cancer stem cells (BCSCs) [142]. The gene discussed is GSTO1; the disease is breast carcinoma.